Royal Victoria Hospital, McGill University Health Centre
Montreal, Quebec, H3A 1A1, Canada
NCT Number: NCT00614133
Loss of muscle mass and body protein are the main causes of fatigue after bowel surgery, which may result in a longer hospital stay and a higher rate of complications. This particularly applies to malnourished patients with cancer who undergo surgery with less muscle protein reserves than patients who are well-nourished. Anesthesiologists can favourably influence these undesirable consequences of surgery by choosing the type of pain treatment, i.e. analgesia. Our group recently observed that pain treatment with epidural catheters (these are placed in the so called epidural space, which lies between the spine and the skin of the back), in contrast to the more conventional use of intravenous morphine, can prevent the loss of body protein after surgery.
The goal of the present research program is to study whether this protein sparing effect of epidural analgesia can be further augmented if we feed our patients intravenously with glucose and protein starting the day prior to surgery. We believe that this new concept will not only avoid the increased protein loss after surgery, but will also help patients to build up new protein which is needed to fight the stress caused by the operation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Montreal, Quebec, H3A 1A1, Canada
The major objective of the nutritional management of surgical patients is to accelerate wound healing and increase resistance to infection while preventing wastage of functional and structural proteins. Parenteral nutrition represents a useful strategy to achieve this goal, particularly in patients undergoing major abdominal procedures with temporary intolerance to oral feeding. At present administration of large, hypercaloric amounts of glucose together with amino acids is the only nutritional modality to establish a positive protein balance (anabolism) after surgery. The fact that hyperalimentation requires central venous cannulation, causes hyperglycemia and is associated with increased morbidity is an impediment to its routine use. Attempts to induce anabolism by diminishing the glucose load to iso- or hypocaloric quantities failed because of
We recently demonstrated that segmental pain relief by epidural analgesia facilitates oxidative glucose utilization thereby decreasing the amount of glucose necessary to attenuate protein losses after surgery. Hypocaloric glucose and epidural analgesia prevented the postoperative increase in protein oxidation, but only if preoperative fasting was avoided, i.e. the glucose infusion was started 24 hours before surgery. We also showed that patients with epidural analgesia could be rendered anabolic by short term administration of glucose and amino acids. Based on our findings of anti-catabolic and anabolic effects of epidural analgesia in the presence of energy and substrate supply we now propose that epidural analgesia and hypocaloric parenteral nutrition initiated 24 hours before colorectal surgery will produce a more positive postoperative protein balance including a greater muscle protein synthesis than when initiated with skin incision.
In order to test the validity of this assumption, patients scheduled for elective colorectal cancer surgery will be randomly assigned to an "early" or "late" feeding protocol. "Early" nutrition will start 24 hours prior to surgery, "late" nutrition will commence with surgical skin incision. Nutrition will be adjusted to provide 50% of the patient's actual energy expenditure as glucose and 20% as amino acids. The stable isotope tracer L-[1-13C]leucine will be applied to assess whole body protein breakdown, amino acid oxidation and protein synthesis. A positive protein balance (difference between protein synthesis and protein breakdown) will be used as an indicator of anabolism. Because whole body protein kinetics provide no insight into metabolic processes at organ level (muscle, liver), the fractional synthesis rates of albumin, fibrinogen and muscle protein will also be determined after surgery.
The demonstration of anabolic effects of epidural analgesia and nutrition with less than half the commonly used energy would have a valuable practical application. If the nutrient load can be decreased, use can be made of peripheral veins and hyperglycemia can be avoided, thus making nutritional therapy more efficacious, safer and available to more patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Glucose and amino acids intravenously starting 20 hours before the operation until the second postoperative day. Glucose provides 50% and amino acids 20% of each patient's measured resting energy expenditure.
Glucose and amino acids intravenously starting with surgical skin incision until the second postoperative day. Glucose provides 50% and amino acids 20% of each patient's measured resting energy expenditure.
Time frame: two days after surgery
Time frame: two days after surgery
McGill University Health Centre/Research Institute of the McGill University Health Centre
Other
Hypocaloric Isonitrogenous Nutrition and Epidural Analgesia: a Novel Strategy to Induce Anabolism After Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01414946
Postoperative Protein Catabolism
Montreal, Quebec, Canada
View Trial DetailsNCT07620106
Hyperphagia, Malnourished Patients Requiring Artificial Nutritional Support
Bari, BA, Italy
View Trial DetailsNCT07604857
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT06556277
Body Weight, Glucocorticoids
Basel, Canton of Basel-City, Switzerland
View Trial Details